| EMA number | EMEA/H/C/001128 |
| ATC code | L01AX03 |
| Authorisation | 15 March 2010 |
| Withdrawn | 15 September 2022 |
| Revision | 17 |
For the treatment of adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy (RT) and subsequently as monotherapy treatment. For the treatment of children from the age of three years, adolescents and adult patients with malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.